US › Healthcare

Envoy Medical Inc. (COCH)

US · Healthcare · Medical Devices

$0.67+3.57%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$51,000

Revenue YoY

-34.6%

Net profit

$-6.0M

EPS

$-0.07

EPS estimate

$-0.09

Net margin

-11,729.4%

EPS came in at -0.07 against a street estimate of -0.09 — a beat of 22.2%.

Key statistics

Market cap

$49.2M

Forward P/E

0.0

P/B

14.98

Book value

$0.05

EPS (TTM)

$-0.76

52-week high

$0.95

52-week low

$0.36

50-day MA

$0.71

200-day MA

$0.69

Beta

1.95

Analyst view

Analysts rate Envoy Medical Inc. a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $2.17.

Shareholding

Insiders

40.23%

Institutions

23.25%

Largest institutional holders

Fund	Stake
Nantahala Capital Management, LLC	19.77%
Bleichroeder LP	8.08%
Vanguard Capital Management, LLC	1.14%
Geode Capital Management, LLC	0.70%
The Colony Group LLC	0.55%
Vanguard Fiduciary Trust Co	0.38%
UBS Group AG	0.25%
Arcus Capital Partners LLC	0.24%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Envoy Medical Inc. — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.